SG Americas Securities LLC Buys 66,698 Shares of Inspire Medical Systems, Inc. $INSP

SG Americas Securities LLC boosted its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 173.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 105,147 shares of the company’s stock after purchasing an additional 66,698 shares during the period. SG Americas Securities LLC owned about 0.37% of Inspire Medical Systems worth $5,423,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Wellington Management Group LLP bought a new position in shares of Inspire Medical Systems in the fourth quarter worth approximately $203,929,000. M&T Bank Corp bought a new stake in Inspire Medical Systems during the 4th quarter valued at $85,871,000. Deerfield Management Company L.P. boosted its position in Inspire Medical Systems by 648.4% during the 3rd quarter. Deerfield Management Company L.P. now owns 1,047,694 shares of the company’s stock valued at $77,739,000 after buying an additional 907,694 shares during the period. Morgan Stanley boosted its position in Inspire Medical Systems by 179.5% during the 4th quarter. Morgan Stanley now owns 1,259,762 shares of the company’s stock valued at $116,188,000 after buying an additional 809,121 shares during the period. Finally, Fuller & Thaler Asset Management Inc. bought a new stake in Inspire Medical Systems in the 4th quarter worth $61,619,000. Institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Stock Performance

Inspire Medical Systems stock opened at $45.65 on Monday. The stock’s 50 day simple moving average is $45.52 and its two-hundred day simple moving average is $65.11. The stock has a market cap of $1.32 billion, a price-to-earnings ratio of 10.17, a PEG ratio of 4.63 and a beta of 0.73. Inspire Medical Systems, Inc. has a fifty-two week low of $38.91 and a fifty-two week high of $147.03.

Inspire Medical Systems (NYSE:INSP) last announced its earnings results on Monday, May 4th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.28) by $0.38. The firm had revenue of $204.58 million during the quarter, compared to analyst estimates of $200.04 million. Inspire Medical Systems had a return on equity of 10.35% and a net margin of 14.33%.The business’s revenue was up 1.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.10 EPS. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. On average, analysts predict that Inspire Medical Systems, Inc. will post 0.93 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on INSP shares. Wells Fargo & Company decreased their price objective on shares of Inspire Medical Systems from $70.00 to $56.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 5th. Bank of America cut Inspire Medical Systems from a “neutral” rating to an “underperform” rating and set a $39.00 target price on the stock. in a research note on Friday, May 22nd. Piper Sandler lowered Inspire Medical Systems from an “overweight” rating to a “neutral” rating and lowered their price target for the company from $85.00 to $55.00 in a research report on Tuesday, May 5th. Oppenheimer reiterated a “market perform” rating on shares of Inspire Medical Systems in a report on Monday, June 15th. Finally, JPMorgan Chase & Co. cut their price objective on Inspire Medical Systems from $67.00 to $54.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 5th. Four equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $81.05.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.